Oral iron therapy with ferrous fumarate and polysaccharide iron complex.
Oral iron replacement therapy with Chromagen, containing ferrous fumarate, and Niferex, containing polysaccharide iron complex, can successfully maintain hematologic and iron indices in dialysis clients and demonstrated fewer adverse effects in selected clients. Their multiple ingredient dose forms, which further support erythropoiesis, and their possible decrease in distressing side effects should enhance client compliance, making these two drugs excellent alternatives to traditional iron therapies.
Glassman
E
E
D000284:Administration, Oral; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology / Q000451:nursing; D000075202:Contraindications; D005290:Ferric Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D000077605:Ferric Oxide, Saccharated; D005296:Ferrous Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D005937:Glucaric Acid; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000628:therapy; D006435:Renal Dialysis / Q000451:nursing
D005290:Ferric Compounds; D005296:Ferrous Compounds; D000077605:Ferric Oxide, Saccharated; D005937:Glucaric Acid; C031621:ferrous fumarate